DIMI what? What!Also no mention of using proceeds from the raise towards starting the DIMI trial.
What is going on here!
"The Company intends to use the net proceeds from the Offering for its Phase III registration trial (Tigris) for its PMX (as defined below) treatment for endotoxemic septic shock and for general corporate and working capital purposes."